The first coronavirus vaccine developed in India has an efficacy rate of 81%, Covaxin’s maker Bharat Biotech said on Wednesday. Here is all you need to know about it and what it means:
Center for Policy, Implementation and Governance Research
Center for Policy, Implementation and Governance Research
The first coronavirus vaccine developed in India has an efficacy rate of 81%, Covaxin’s maker Bharat Biotech said on Wednesday. Here is all you need to know about it and what it means:
